Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer.
Saved in:
| Title: | Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer. |
|---|---|
| Authors: | Luo, Linjie1 (AUTHOR) lluo2@mdanderson.org, Yang, Peng2,3 (AUTHOR), Mastoraki, Sofia1 (AUTHOR), Rao, Xiayu4 (AUTHOR), Wang, Yan1 (AUTHOR), Kettner, Nicole M.1 (AUTHOR), Raghavendra, Akshara Singareeka5 (AUTHOR), Tripathy, Debasish5 (AUTHOR), Damodaran, Senthil5 (AUTHOR), Hunt, Kelly K.6 (AUTHOR), Wang, Jing4 (AUTHOR), Li, Ziyi3 (AUTHOR), Keyomarsi, Khandan1 (AUTHOR) kkeyomar@mdanderson.org |
| Source: | Molecular Cancer. 2/15/2025, Vol. 24 Issue 1, p1-28. 28p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14764598 |
|---|---|
| DOI: | 10.1186/s12943-025-02226-9 |
